Viatris Earnings
NASDAQ: VTRSHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$0.65
Viatris earnings summary
Viatris is scheduled to report Sep/2026 earnings on Nov 5, 2026 before the market opens, with analysts expecting EPS of $0.65. In its most recent report on Aug 6, 2026 (Q2 2026), VTRS posted EPS of $-0.10. Revenue for the quarter was $3.76 billion.
Across the last 16 reports, VTRS shares moved an average of 3.5% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
VTRS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.10 | — | -1.2% |
| May 7, 2026 | — | $0.15 | — | -4.0% |
| Feb 26, 2026 | — | $-0.34 | — | -5.2% |
| Nov 6, 2025 | — | $-0.11 | — | +5.9% |
| Aug 7, 2025 | — | $0.00 | — | +9.4% |
| May 8, 2025 | — | $-2.55 | — | +0.8% |
| Feb 27, 2025 | — | $-0.43 | — | +4.6% |
| Nov 7, 2024 | — | $0.08 | — | -1.0% |
| Aug 8, 2024 | — | $-0.27 | — | -1.0% |
| May 9, 2024 | — | $0.09 | — | -1.6% |
| Feb 28, 2024 | — | $-0.63 | — | -2.6% |
| Nov 8, 2023 | — | $0.27 | — | +2.7% |
| Aug 7, 2023 | — | $0.22 | — | -0.8% |
| May 8, 2023 | — | $0.19 | — | +0.5% |
| Feb 27, 2023 | — | $0.83 | — | -10.2% |
| Nov 7, 2022 | — | $0.29 | — | -3.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.